Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Neuroleptic malignant syndrome – a clinical conundrum

Venkatesan Srinivasan
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.19-2-s1
Clin Med March 2019
Venkatesan Srinivasan
MGR Medical University Institute of Neurology, Madras Medical College, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Aims

To study the clinical conundrum of neuroleptic malignant syndrome (NMS) in schizophrenia and affective disorders when studied separately.

Methods

Twenty people with schizophrenia and 30 patients with affective disorder that developed NMS were studied between 1990 and 2001 prospectively. Modified criteria of Keck was used for the diagnosis of NMS. Only patients who developed fever, altered sensorium, extrapyramidal and autonomic symptoms are included. Standard statistical data analysis was performed.

Results

Mean age onset in schizophrenia was 32 years (18–58 years) and in affective disorders was 43 years (15–73 years). NMS developed within 9 hours of starting therapy and lasted for a mean duration of 23 days. In the affective disorder group, NMS developed over a period of 17 hours and lasted for a mean duration of 11 days. Fever occurred in all the cases and earlier in schizophrenia (11.9 hours), compared with affective disorders (16.8 hours). The altered sensorium occurred within 9.6 hours in schizophrenia and 25.69 hours in affective disorder. The rigidity occurred in 38.8 hours in schizophrenia and 84.9 hours in affective disorder. Rigidity followed fever and altered sensorium in both the conditions. Autonomic symptoms occurred within 48 hours in schizophrenia and 107 hours in affective disorder.

The correlation analysis showed correlation between NMS onset with fever and altered sensorium. Cluster analysis indicated that autonomic and extrapyramidal symptoms cause for the evolution of NMS. The factor analysis of the parameter responsible for NMS in people with schizophrenia and extrapyramidal symptoms 0.913, autonomic symptoms 0.858, fever 0.779, altered sensorium 0.497, whereas in affective disorders extrapyramidal symptoms 0.931, autonomous symptoms 0.955, fever 0.200, altered sensorium 0.181 – AVS–CUV Criterion.1 Four patients died in the schizophrenic patient group. Discriminate analysis showed autonomic symptoms (0.9), extrapyramidal symptoms (0.7), altered sensorium (0.6) and fever (0.3). The misclassification rates in the case of schizophrenia are 1.5% and affective disorder is 7%. ­Re-exposure of neuroleptics were started in 10 patients after 12 weeks. During 6-month ­follow–up, they did not develop NMS.

Conclusion

NMS developed earlier and look a longer time to resolve in patients with schizophrenia compared with those with affective disorders. Mortality occurred only in patients with schizophrenia. New AVS–CUV criteria has been added to the word literature.

Conflict of interest statement

There is no conflict of interest.

  • © Royal College of Physicians 2019. All rights reserved.

Reference

  1. ↵
    1. Srinivasan AV,
    2. et al.
    , presented at XXIV The International College of Neuropsychopharmacology (CINP) Congress. Paris: 20–24 June 2004.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Neuroleptic malignant syndrome – a clinical conundrum
Venkatesan Srinivasan
Clinical Medicine Mar 2019, 19 (Suppl 2) 1; DOI: 10.7861/clinmedicine.19-2-s1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Neuroleptic malignant syndrome – a clinical conundrum
Venkatesan Srinivasan
Clinical Medicine Mar 2019, 19 (Suppl 2) 1; DOI: 10.7861/clinmedicine.19-2-s1
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Aims
    • Methods
    • Results
    • Conclusion
    • Conflict of interest statement
    • Reference
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Time to recognition, aetiology, antibiotic sensitivity ­pattern and outcome of sepsis in a tertiary care hospital in Sri Lanka
  • Probiotics’ effects on perception of health and bowel frequency: a double-blind, randomised, placebo-controlled clinical trial
  • The frequency and pattern of cognitive impairment in the elderly at the outpatients clinic of the Holy Family Hospital, Techiman, Ghana
Show more Clinical

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians